STAT17d
Patrizia Cavazzoni, head of FDA’s drug center, to leave the agency
Patrizia Cavazzoni, leader of the Food and Drug Administration ... will take Cavazzoni’s place pending ethics clearance, FDA Commissioner Robert Califf said in an email reviewed by STAT.
FiercePharma17d
FDA's Patrizia Cavazzoni to retire as CDER chief in 2nd senior official's departure in span of weeks
The FDA’s influential director of the Center for Drug Evaluation and Research, Patrizia Cavazzoni, M.D., will soon retire from the agency. The seven-year FDA veteran communicated the decision in ...
Hosted on MSN16d
FDA CDER director Patrizia Cavazzoni announces resignation
The US Food and Drugs Administration (FDA) has confirmed that its director of the Centre for Drug Evaluation and Research (CDER), Patrizia Cavazzoni, has announced her resignation ahead of Donald ...
Becker's Hospital Review17d
FDA drug evaluation leader to exit
The director of the FDA's Center for Drug Evaluation and Research, Patrizia Cavazzoni, MD, will step down from the role Jan. 18, according to an Endpoints News report. Dr. Cavazzoni joined the FDA ...
JD Supra7d
Drugs and Biologics at FDA: Reflections on 2024 Activity Shed Light on the Road Ahead
With each new year comes a new set of accompanying challenges, from tackling the latest innovations to new incarnations of old issues. 2025 will be ...
Benzinga.com17d
Patrizia Cavazzoni, head of FDA's drug center, to leave the agency
Patrizia Cavazzoni, leader of the Food and Drug Administration’s Center for Drug Evaluation and Research, is leaving the agency on Jan. 18. The director shared the news with staff on Friday ...
Pharmaceutical Technology17d
FDA CDER director Patrizia Cavazzoni announces resignation
Following a string of FDA resignations, Patrizia Cavazzoni has announced that her last day will be 18 January. Merging industry-leading business intelligence & award-winning journalism, this is an ...